Description
Semax + Selank Blend (10mg/10mg) — nootropic and anxiolytic stack for research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
This blend combines two well-characterised Russian pharmaceutical peptides in a precise 1:1 ratio. Both Semax and Selank are approved drugs in Russia with decades of research, and both share the stabilising Pro-Gly-Pro (PGP) modification.
What the Research Shows
Semax research focuses on BDNF expression, cognitive function, and neuroprotection through ACTH(4-10) fragment activity. Selank research examines GABAergic neurotransmission, anxiety modulation, and immunomodulatory effects through tuftsin-based activity.
The combination allows investigation of potential interactions between nootropic and anxiolytic mechanisms in a single preparation with simplified dosing.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity for both components. No generic overseas certificates.
→ Explore the Peptide Research Library
Purity: ≥99% each component (HPLC)
Form: Lyophilised powder
Semax: 10mg (MW: 813.97 Da)
Selank: 10mg (MW: 751.9 Da)
Total: 20mg
Research: PubMed
▸ Australian university verified
▸ ≥99% purity both components
▸ Same-day dispatch from Sydney
▸ Accurate 1:1 ratio
Related Research and Resources
For research use only. Not for human consumption.




